Evidence map›Paper›PMID 40072622›Full record

ArticleArchives of dermatological research2025

Correction: Ritlecitinib, a JAK3 /TEC inhibitor, modulates the markers of celiac autoimmunity in alopecia areata and vitiligo patients.

Rok Seon Choung, Jyoti Ramakrishna, Vivek Pradhan, Brett King, Emma Guttman-Yassky, Elena Peeva, Joseph A Murray

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Rok Seon ChoungDivision of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA. Choung.rokson@mayo.edu.
Jyoti RamakrishnaInflammation and Immunology Research Unit, Pfizer R&D, Cambridge, MA, USA.
Vivek PradhanInflammation and Immunology Research Unit, Pfizer R&D, Cambridge, MA, USA.
Brett KingDepartment of Dermatology, Yale School of Medicine, New Haven, Connecticut, USA.
Emma Guttman-YasskyDepartment of Dermatology and the Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Elena PeevaInflammation and Immunology Research Unit, Pfizer R&D, Cambridge, MA, USA.
Joseph A MurrayDivision of Gastroenterology and Hepatology, 200 1st Street SW, Rochester, MN, 55905, USA. murray.joseph@mayo.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40072622
PMCPMC11903507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.